Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HT
576
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $915K | ﹤0.01% |
93,295
+83,030
| +809% | +$831K |
|
577
Columbia Banking Systems
COLB
$8.99B
| $911K | ﹤0.01% |
31,800
-4
| -0% | -$118 |
|
578
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.43B
| $905K | ﹤0.01% |
7,125
+3,371
| +90% | +$504K |
|
579
Linde
LIN
$223B
| $886K | ﹤0.01% |
3,080
+695
| +29% | +$217K |
|
580
HP
HPQ
$26.4B
| $881K | ﹤0.01% |
26,876
+11,018
| +69% | +$404K |
|
|
BZUN
581
Baozun
BZUN
$176M
| $877K | ﹤0.01% |
80,202
-100
| -0.1% | -$879 |
|
582
State Street SPDR S&P Metals & Mining ETF
XME
$4.12B
| $822K | ﹤0.01% |
18,938
-594
| -3% | -$32.3K |
|
583
Papa John's
PZZA
$1.01B
| $818K | ﹤0.01% |
9,793
-2,391
| -20% | -$215K |
|
584
Waste Management
WM
$90B
| $810K | ﹤0.01% |
5,295
+394
| +8% | +$61.7K |
|
585
W.P. Carey
WPC
$16.5B
| $793K | ﹤0.01% |
9,774
+3,910
| +67% | +$316K |
|
|
SNV
586
DELISTED
Synovus
SNV
| $771K | ﹤0.01% |
21,386
| – | – |
|
587
Paychex
PAYX
$42.2B
| $767K | ﹤0.01% |
6,740
+4,081
| +153% | +$513K |
|
588
SouthState Bank Corp
SSB
$10.6B
| $765K | ﹤0.01% |
9,915
+177
| +2% | +$13.8K |
|
589
Vanda Pharmaceuticals
VNDA
$321M
| $759K | ﹤0.01% |
69,588
| – | – |
|
590
EPAM Systems
EPAM
$5.85B
| $758K | ﹤0.01% |
2,572
+91
| +4% | +$27.8K |
|
591
Renasant Corp
RNST
$4.05B
| $757K | ﹤0.01% |
26,268
+7,053
| +37% | +$216K |
|
592
Fortinet
FTNT
$123B
| $756K | ﹤0.01% |
13,359
+2,689
| +25% | +$160K |
|
593
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.83B
| $753K | ﹤0.01% |
8,627
+560
| +7% | +$53.2K |
|
594
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $744K | ﹤0.01% |
10,312
-1,597
| -13% | -$120K |
|
595
Broadstone Net Lease
BNL
$4.06B
| $735K | ﹤0.01% |
35,858
| – | – |
|
596
Gilead Sciences
GILD
$168B
| $727K | ﹤0.01% |
11,765
+5,397
| +85% | +$334K |
|
597
Zimmer Biomet
ZBH
$18.5B
| $724K | ﹤0.01% |
6,891
-329
| -5% | -$39K |
|
598
Parsons
PSN
$5.19B
| $723K | ﹤0.01% |
+17,877
| New | +$685K |
|
599
iShares MSCI Taiwan ETF
EWT
$10.6B
| $722K | ﹤0.01% |
14,329
+4,527
| +46% | +$252K |
|
600
iShares US Aerospace & Defense ETF
ITA
$14.7B
| $719K | ﹤0.01% |
7,247
-3,002
| -29% | -$309K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.